| To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects (NCT05982106) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-07-19 |
| Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001 (NCT05657184) | Regend Therapeutics | 2021-07-19 |
| A Study of a Hydrocolloid Bandage on Pimples (NCT05012735) | Johnson & Johnson Consumer Inc. (J&JCI) | 2021-07-19 |
| Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer (NCT04639245) | Fred Hutchinson Cancer Center | 2021-07-19 |
| A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK (NCT05357820) | Nuvation Bio Inc. | 2021-07-19 |
| Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) (NCT04956640) | Eli Lilly and Company | 2021-07-19 |
| Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience (NCT05074485) | Alan Prossin | 2021-07-19 |
| A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State (NCT07030439) | Impact Therapeutics, Inc. | 2021-07-18 |
| Breathing and Attention Training for Chronic Low Back Pain (NCT04740710) | University of Florida | 2021-07-18 |
| Cefiderocol PK in Patients on ECMO (NCT04995835) | Joseph L. Kuti, PharmD | 2021-07-16 |
| Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma (NCT04911816) | West Virginia University | 2021-07-16 |
| A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose (NCT04973111) | Carmot Therapeutics, Inc. | 2021-07-16 |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours (NCT04969835) | Avacta Life Sciences Ltd | 2021-07-16 |
| Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors (NCT04485416) | University of California, Davis | 2021-07-16 |
| Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy (NCT04868773) | University of California, Irvine | 2021-07-16 |
| Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 (NCT04895449) | Universitätsklinikum Hamburg-Eppendorf | 2021-07-16 |
| Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer (NCT04750473) | Emory University | 2021-07-16 |
| A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects (NCT05225974) | The Affiliated Hospital of Qingdao University | 2021-07-16 |
| A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants (NCT04965389) | Bristol-Myers Squibb | 2021-07-16 |
| Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim (NCT04970342) | Timothy L. Brown | 2021-07-16 |
| Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir (NCT04962230) | Pfizer | 2021-07-15 |
| Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery (NCT04685421) | Nicklaus Children's Hospital f/k/a Miami Children's Hospital | 2021-07-15 |
| A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects (NCT04976309) | H. Lundbeck A/S | 2021-07-15 |
| An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients (NCT04967950) | Peking Union Medical College Hospital | 2021-07-15 |
| A Phase 1b Study of ZN-c3 in Chinese Subjects (NCT04972422) | Zentera Therapeutics HK Limited | 2021-07-15 |
| Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab (NCT04748419) | University of Nebraska | 2021-07-15 |
| Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD (NCT04993352) | Shanghai Henlius Biotech | 2021-07-15 |
| Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device (NCT04918823) | Boston Sight | 2021-07-15 |
| Personalized Vaccine for Patients With Recurrent Malignant Glioma (NCT04943718) | Xuanwu Hospital, Beijing | 2021-07-15 |
| First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers (NCT04795037) | Curacle Co., Ltd. | 2021-07-15 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants (NCT04965402) | Bristol-Myers Squibb | 2021-07-15 |
| A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) (NCT04913220) | Sanofi | 2021-07-15 |
| Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment (NCT04826003) | Hoffmann-La Roche | 2021-07-14 |
| SBRT in Chagas Disease Ventricular Tachycardia (NCT04984265) | University of Sao Paulo General Hospital | 2021-07-14 |
| The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products (NCT04741477) | Johns Hopkins University | 2021-07-14 |
| A Study in Healthy Men to Test Whether Four Capsules of 25 mg Nintedanib Are Taken up in the Body in the Same Way as One 100 mg Capsule (NCT04938453) | Boehringer Ingelheim | 2021-07-14 |
| Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction (NCT04340180) | University of Alabama at Birmingham | 2021-07-14 |
| Partial Scalp Block in Posterior Fossa Surgery (NCT04955236) | Kasr El Aini Hospital | 2021-07-14 |
| Salivary Fluoride Clearance (NCT06735235) | Procter and Gamble | 2021-07-14 |
| Oral Amoxicillin and Cephalexin PK/PD in Neonates (NCT04916951) | University of Colorado, Denver | 2021-07-14 |
| A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People (NCT05127473) | Novo Nordisk A/S | 2021-07-14 |
| A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus (NCT04957914) | Eli Lilly and Company | 2021-07-14 |
| Single-dose Mass Balance Recovery and Metabolite Profile and Identification of 14C-XEN1101 (NCT04952467) | Xenon Pharmaceuticals Inc. | 2021-07-14 |
| PAVS in Cardiology (NCT04656132) | NYU Langone Health | 2021-07-14 |
| A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors (NCT04801095) | Wellmarker Bio | 2021-07-14 |
| Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) (NCT04839367) | Clarity Pharmaceuticals Ltd | 2021-07-13 |
| Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults (NCT04966832) | XWPharma | 2021-07-13 |
| AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer (NCT04993391) | Suzhou Junjing BioSciences Co., Ltd. | 2021-07-13 |
| Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers (NCT04942652) | Seoul National University Hospital | 2021-07-13 |
| To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects (NCT04945616) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-13 |
| Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer (NCT04737109) | David VanderWeele | 2021-07-13 |
| Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis (NCT04551131) | St. Jude Children's Research Hospital | 2021-07-13 |
| Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants (NCT04994743) | Corcept Therapeutics | 2021-07-13 |
| Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) (NCT04760730) | R-Pharm | 2021-07-13 |
| A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin (NCT05357911) | Nuvation Bio Inc. | 2021-07-13 |
| A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer (NCT04898634) | Janssen Research & Development, LLC | 2021-07-13 |
| US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease (NCT04594031) | ExCellThera inc. | 2021-07-13 |
| NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome (NCT04977388) | Stephen G. Kaler, MD | 2021-07-12 |
| FT819 in Subjects With B-cell Malignancies (NCT04629729) | Fate Therapeutics | 2021-07-12 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Atrosimab (ATM001) in Healthy Volunteers (NCT04650126) | Baliopharm Pty Ltd | 2021-07-12 |
| Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML (NCT04887259) | Lava Therapeutics | 2021-07-12 |
| Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma (NCT04926948) | Mayo Clinic | 2021-07-12 |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma (NCT04983810) | Cyclacel Pharmaceuticals, Inc. | 2021-07-12 |
| Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers (NCT04975711) | Hanmi Pharmaceutical Company Limited | 2021-07-12 |
| Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors (NCT04830501) | TransThera Sciences (Nanjing), Inc. | 2021-07-12 |
| Melatonin Use After Primary Total Joint Arthroplasty (NCT04795336) | NYU Langone Health | 2021-07-12 |
| A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers (NCT04972188) | Zydus Lifesciences Limited | 2021-07-12 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects (NCT04906109) | Dong-A ST Co., Ltd. | 2021-07-12 |
| GW117 ODT （Orally Disintegrating Tablets） Safety and Pharmacokinetics Study in Healthy Subjects (NCT06964711) | Beijing Greatway Pharmaceutical Technology Co.,Ltd. | 2021-07-12 |
| Universal Anti-Viral Vaccine for Healthy Elderly Adults (NCT04441047) | Mirror Biologics, Inc. | 2021-07-12 |
| PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects (NCT07456800) | PureTech | 2021-07-12 |
| Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT04982068) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-07-12 |
| Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects (NCT05519514) | Abbott | 2021-07-12 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects (NCT04965337) | Ascletis Pharmaceuticals Co., Ltd. | 2021-07-11 |
| Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma (NCT04547777) | Darell Bigner | 2021-07-09 |
| Study of ALXN2050 in Healthy Adult Participants of Japanese Descent (NCT04952545) | Alexion Pharmaceuticals, Inc. | 2021-07-09 |
| Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil (NCT04993209) | Butantan Institute | 2021-07-09 |
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma (NCT04739813) | National Cancer Institute (NCI) | 2021-07-09 |
| Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia (NCT04996160) | Tanja Andrea Gruber | 2021-07-09 |
| Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer (NCT05035914) | Guangzhou University of Traditional Chinese Medicine | 2021-07-09 |
| Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function (NCT04810598) | AbbVie | 2021-07-08 |
| High Fiber in Parkinson's Disease (NCT04976959) | Rutgers, The State University of New Jersey | 2021-07-08 |
| Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults (NCT04927585) | Worcester HIV Vaccine | 2021-07-08 |
| Cannabis Effects as a Function of Sex (NCT04385082) | University of California, Los Angeles | 2021-07-08 |
| A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment (NCT04872634) | NKMAX Co., Ltd. | 2021-07-08 |
| Gut Butyrate and Blood Pressure in African Americans (NCT04415333) | University of North Carolina, Chapel Hill | 2021-07-08 |
| Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811) (NCT04938752) | Dong-A ST Co., Ltd. | 2021-07-08 |
| ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT05010122) | M.D. Anderson Cancer Center | 2021-07-08 |
| pAF for the Treatment of Osteoarthritis (NCT04886960) | University of Utah | 2021-07-08 |
| Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus (NCT05007977) | Zucara Therapeutics Inc. | 2021-07-08 |
| A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers (NCT05040880) | HK inno.N Corporation | 2021-07-08 |
| A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants (NCT04963439) | Actelion | 2021-07-08 |
| ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration (NCT04744662) | ONL Therapeutics | 2021-07-08 |
| A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma (NCT05011097) | Wuhan YZY Biopharma Co., Ltd. | 2021-07-08 |
| Study of ALXN2050 in Participants With Renal Impairment (NCT04623710) | Alexion Pharmaceuticals, Inc. | 2021-07-08 |
| Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy (NCT04037462) | VA Office of Research and Development | 2021-07-07 |
| A Study to Explore the Effect of Acid-reducing Agents (NCT04935112) | Mirati Therapeutics Inc. | 2021-07-07 |
| IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics (NCT04982705) | IlDong Pharmaceutical Co Ltd | 2021-07-07 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus (NCT04889157) | Pfizer | 2021-07-07 |
| Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers (NCT06049147) | Medibiofarma S.L. | 2021-07-07 |